YipJ., VescanA.D., WitterickI.J.The personal financial burden of chronic rhinosinusitis: A Canadian perspective.Am J Rhinol Allergy31: 216–221, 2017.
2.
HoehleL.P., SpethM.M., PhillipsK.M.Association between symptoms of allergic rhinitis with decreased general health-related quality of life.Am J Rhinol Allergy31: 235–239, 2017.
GuoY., YanqingL., WangD.A randomized double-blind placebo controlled trial of sublingual immunotherapy with house-dust mite extract for allergic rhinitis.Am J Rhinol Allergy31: e42–e47, 2017.
5.
ChenJ., WangX., ChenL.Influence of hyaluronan nasal dressing on clinical outcome after endoscopic sinus surgery: A systematic review and meta-analysis.Am J Rhinol Allergy31: 256–259, 2017.
6.
LangeJ.L., PeedenE.H., and StringerS.P.Are prophylactic systemic antibiotics necessary with nasal packing? A systematic review.Am J Rhinol Allergy31: 240–247, 2017.
7.
PrasadS., FongE., and OoiE.H.Systematic review of patient reported outcomes after revision endoscopic sinus surgery.Am J Rhinol Allergy31: 248–255, 2017.
8.
JiamN.T.L., GoldbergA.N., MurrA.H.Surgical treatment of chronic rhinosinusitis after sinus lift.Am J Rhinol Allergy31: 271–275, 2017.
9.
ChandraR.K.Endoscopic septoplasty: How I do it.Am J Rhinol Allergy31: 276–277, 2017.
10.
ScattolinA., GalzignatoP-F, LongariF.Septal extension graft in “closed” revision rhinoplasty: A simplified technique.Am J Rhinol Allergy31: 260–264, 2017.
11.
JafariA., TringaleK.R., PanugantiB.A.Short-term morbidity after the endoscopic modified Lothrop (Draf-III) procedure compared with Draf-IIa.Am J Rhinol Allergy31: 265–270, 2017.
12.
CareyR.M., WorkmanA.D., YanC.H.Sinonasal T2R-mediated nitric oxide production in response to Bacillus cereus.Am J Rhinol Allergy31: 211–215, 2017.
13.
LeeE.J., HwangH.J., JungC.M.The relationship between chronic rhinosinusitis and metabolic syndrome.Am J Rhinol Allergy31: 222–227, 2017.
14.
DuJ., MaoH., OuyangH.Osteopontin induced vascular endothelial growth factor production in dispersed nasal polyp cells through the phosphatidylinositol 3-kinase–protein kinase B and the extracellular signal-regulated kinase 1/2 pathways.Am J Rhinol Allergy31: e35–e41, 2017.
